These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4906766)

  • 1. A delayed-release theophylline-noscapine formulation for the relief of airways obstruction.
    Darke CS; Picton EA
    Practitioner; 1970 Feb; 204(220):276-81. PubMed ID: 4906766
    [No Abstract]   [Full Text] [Related]  

  • 2. Slow release salbutamol and Tedral in the treatment of reversible airways obstruction.
    Lal S; Bhalla KK; Davey AJ
    Postgrad Med J; 1971 Mar; 47():Suppl:89-92. PubMed ID: 4929401
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
    Baronti A; Verdiani P; Di Carlo S
    Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of a delayed-action cough medicine].
    Linquette M; Cappoen JP
    Lille Med; 1972 Dec; 17():Suppl 8:1614-6. PubMed ID: 4667300
    [No Abstract]   [Full Text] [Related]  

  • 5. The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.
    Nolte D; Dusik B
    Br J Clin Pract Suppl; 1984; 32():18-21. PubMed ID: 6432018
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of obstructive respiratory tract diseases. Study of afonilum retard in 3,512 patients].
    Eichhorn J; Perré R
    Med Welt; 1982 Dec; 33(50):1834-7. PubMed ID: 6762480
    [No Abstract]   [Full Text] [Related]  

  • 7. [Theopek in the treatment of patients with obstructive diseases of the respiratory organs].
    Korzh OB; Vygovskiĭ VP; Stadnicheko RA; Borzhievskaia OE; Kopel'man EI; Kozak KM; Senyk RV; Vygovskiĭ IaV
    Vrach Delo; 1990 Jan; (1):41-2. PubMed ID: 2330707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow release theophylline in patients with airways obstruction with particular reference to the effects of food upon serum levels.
    Thompson PJ; Kemp MW; McAllister WA; Turner-Warwick M
    Br J Dis Chest; 1983 Jul; 77(3):293-8. PubMed ID: 6351891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
    Aamodt T; Lien JT; Haaversen O; Osmundsen K
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of steady state plasma theophylline concentrations with conventional and sustained release formulations.
    Mellstrand T; Svedmyr K; Svedmyr N
    Eur J Respir Dis; 1982 Jan; 63(1):31-4. PubMed ID: 7040098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 21-day double-blind study of the effect of adding sustained-release theophylline (Nuelin SA) to inhaled salbutamol in patients with asthma.
    Sahay JN; Chatterjee SS
    Br J Dis Chest; 1983 Jan; 77(1):66-70. PubMed ID: 6344899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of increasing the evening dose of controlled release theophylline in patients with reversible airways obstruction.
    Haig G
    Br J Clin Pract Suppl; 1984; 32():22-4. PubMed ID: 6432020
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative bioavailability of 2 oral theophylline sustained-release preparations].
    Tritthart W; Lücker PW; Fáy E; Buchebner J
    Arzneimittelforschung; 1983; 33(11):1603-6. PubMed ID: 6686457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D
    Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with theophylline in slow-release form (Theo-dur)].
    Jørstad SO; Omenaas E
    Tidsskr Nor Laegeforen; 1982 May; 102(13):747-9. PubMed ID: 6760450
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trials of celestene-chronodose].
    Ollagnier C; Vallon C
    Rev Lyon Med; 1970 Jun; 19(11):449-59. PubMed ID: 5479195
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
    Kaik G
    Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
    Jones DT; Sears MR
    N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I
    Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.